Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Mouth, Edentulous D009066 1 associated lipids
Pelvic Pain D017699 7 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Uveitis, Anterior D014606 11 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Migraine without Aura D020326 1 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Leukostasis D018921 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Francescangeli E et al. Activation of PAF-synthesizing enzymes in rat brain stem slices after LTP induction in the medial vestibular nuclei. 2002 Neurochem. Res. pmid:12512951
Roy Baker R and Chang Hy MgATP may depress de novo neuronal nuclear PAF generation by promoting the formation of alkylacylglycerophosphate, an inhibitor of alkylglycerophosphate acetyltransferase. 2002 Biochim. Biophys. Acta pmid:12457714
Pan YH et al. Crystal structure of phospholipase A2 complex with the hydrolysis products of platelet activating factor: equilibrium binding of fatty acid and lysophospholipid-ether at the active site may be mutually exclusive. 2002 Biochemistry pmid:12475227
Smith JM et al. Platelet-activating factor and Escherichia coliO157:H7 infections. 2002 Pediatr. Nephrol. pmid:12478356
Makhija R and Kingsnorth AN Cytokine storm in acute pancreatitis. 2002 J Hepatobiliary Pancreat Surg pmid:12483260
Lee YM et al. Platelet-activating factor induces lung inflammation and leak in rats: hydrogen peroxide production along neutrophil-lung endothelial cell interfaces. 2002 J. Lab. Clin. Med. pmid:12434132
Abu-Zidan FM and Windsor JA Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials. 2002 Eur J Surg pmid:12440758
Teather LA et al. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats. 2002 Psychopharmacology (Berl.) pmid:12373444
Baker PR et al. Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases. 2002 Biochim. Biophys. Acta pmid:12379481
Leusch A et al. Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice. 2002 Eur J Pharm Sci pmid:12128165
Megens AA et al. Pharmacological profile of (2R-trans)-4-[1-[3,5-bis(trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an orally and centrally active neurokinin-1 receptor antagonist. 2002 J. Pharmacol. Exp. Ther. pmid:12130734
Podolak-Dawidziak M [Role of white cells and neoplastic cells in haemostasis]. 2002 Pol. Arch. Med. Wewn. pmid:12189915
Strømgaard K et al. Ginkgolide derivatives for photolabeling studies: preparation and pharmacological evaluation. 2002 J. Med. Chem. pmid:12190325
Wong RK et al. Augmentation of the neutrophil respiratory burst through the action of advanced glycation end products: a potential contributor to vascular oxidant stress. 2002 Diabetes pmid:12196480
Goldring WP and Pattenden G A total synthesis of phomactin A. 2002 Chem. Commun. (Camb.) pmid:12196974
Fujiu T et al. Cellular adhesion is required for effector functions of human eosinophils via G-protein coupled receptors. 2002 Ann. Allergy Asthma Immunol. pmid:12141728
Bazan NG et al. What synaptic lipid signaling tells us about seizure-induced damage and epileptogenesis. 2002 Prog. Brain Res. pmid:12143339
McLennan SV et al. Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy. 2002 Diabetes pmid:12145178
Claud EC et al. Platelet-activating factor regulates chloride transport in colonic epithelial cell monolayers. 2002 Pediatr. Res. pmid:12149490
Hostettler ME et al. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3. 2002 Glia pmid:11968060
Boisfer E et al. Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II. 2002 J. Lipid Res. pmid:11971944
Steel HC and Anderson R Dissociation of the PAF-receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium. 2002 Br. J. Pharmacol. pmid:11976271
McKay CJ Recent developments in the management of acute pancreatitis. 2002 Dig Surg pmid:11979001
Roudebush WE et al. Embryonic platelet-activating factor: an indicator of embryo viability. 2002 Hum. Reprod. pmid:11980756
Hostettler ME and Carlson SL PAF antagonist treatment reduces pro-inflammatory cytokine mRNA after spinal cord injury. 2002 Neuroreport pmid:11924887
Barletta E et al. Platelet activating factor inhibits the expression of matrix metalloproteinases and affects invasiveness and differentiation in a system of human neuroblastoma clones. 2002 Biol. Chem. pmid:11928813
Larrucea S et al. Agonist-induced aggregation of Chinese hamster ovary cells coexpressing the human receptors for fibrinogen (integrin alphaIIbbeta3) and the platelet-activating factor: dissociation between adhesion and aggregation. 2002 Blood pmid:11929771
Benito E and Bosch MA Role of platelet-activating factor in phosphatidylcholine secretion in primary cultures of rat type II pneumocytes. 2002 Prostaglandins Other Lipid Mediat. pmid:12013527
Acuña AA et al. Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma. 2002 Eur. Respir. J. pmid:12030727
Steel HC et al. Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro. 2002 APMIS pmid:12064871
Yoshikawa M et al. Effect of extracellular matrix proteins on platelet-activating factor-induced eosinophil chemotaxis. 2002 Int. Arch. Allergy Immunol. pmid:12065903
Nakamura T et al. Relationship between the platelet activating factor acetylhydrolase gene and intractability of ulcerative colitis. 2002 Dis. Colon Rectum pmid:12068200
Silva-Neto MA et al. Platelet-activating factor (PAF) activates casein kinase 2 in the protozoan parasite Herpetomonas muscarum muscarum. 2002 Biochem. Biophys. Res. Commun. pmid:12054663
Kingston JK et al. Effects of formaldehyde fixation on equine platelets using flow cytometric methods to evaluate markers of platelet activation. 2002 Am. J. Vet. Res. pmid:12061530
Zhou ZG and Chen YD Influencing factors of pancreatic microcirculatory impairment in acute panceatitis. 2002 World J. Gastroenterol. pmid:12046059
Kato T et al. Mitochondrial calcium response in human transformed lymphoblastoid cells. 2002 Life Sci. pmid:12052442
Haynes J and Obiako B Activated polymorphonuclear cells increase sickle red blood cell retention in lung: role of phospholipids. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:11748055
Christie PE and Henderson WR Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor. 2002 Clin Allergy Immunol pmid:11577541
Ibe BO et al. Metabolism of platelet activating factor by intrapulmonary vascular smooth muscle cells. Effect of oxygen on phospholipase A2 protein expression and activities of acetyl-CoA acetyltransferase and cholinephosphotransferase. 2002 Mol. Genet. Metab. pmid:12409272
Childs EW et al. In vivo visualization of reactive oxidants and leukocyte-endothelial adherence following hemorrhagic shock. 2002 Shock pmid:12412620
Eikelboom JW et al. Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes. 2002 Eur. Heart J. pmid:12419297
Tanaka S and Koike T Selective inflammatory stimulations enhance release of microglial response factor (MRF)-1 from cultured microglia. 2002 Glia pmid:12420315
Cuschieri J et al. Platelet-activating factor priming of inflammatory cell activity requires cellular adherence. 2002 Surgery pmid:12219006
Kato M et al. Platelet-activating factor activates two distinct effector pathways in human eosinophils. 2002 J. Immunol. pmid:12391244
Ueno H et al. Coagulation/fibrinolysis abnormality and vascular endothelial damage in the pathogenesis of thrombocytopenic multiple organ failure. 2002 Crit. Care Med. pmid:12394951
Tsuyuki K et al. Possible participation of intracellular platelet-activating factor in NF-kappaB activation in rat peritoneal macrophages. 2002 Biochim. Biophys. Acta pmid:12069846
Sakamoto H et al. Overexpression of phospholipid hydroperoxide glutathione peroxidase modulates acetyl-CoA, 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase activity. 2002 J. Biol. Chem. pmid:12397078
Ichinowatari G et al. Participation of prostaglandin E2 and platelet-activating factor in thapsigargin-induced production of interleukin-6. 2002 Eur. J. Pharmacol. pmid:11779582
Klein A et al. Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice. 2002 Br. J. Pharmacol. pmid:11877329
Bulger EM et al. The macrophage response to endotoxin requires platelet activating factor. 2002 Shock pmid:11900334
Mitsuoka H et al. Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock. 2002 Shock pmid:11900339
Kondratskaya EL et al. BN52021, a platelet activating factor antagonist, is a selective blocker of glycine-gated chloride channel. 2002 Neurochem. Int. pmid:11900860
Hu G et al. Isoflurane inhibits neutrophil-endothelium interactions in the coronary circulation: lack of a role for adenosine triphosphate-sensitive potassium channels. 2002 Anesth. Analg. pmid:11916783
Ozgün H et al. Lexipafant inhibits postsurgical adhesion formation. 2002 J. Surg. Res. pmid:11922727
Cellai C et al. Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells. 2002 FASEB J. pmid:11923217
Rivera A et al. Modulation of Gardos channel activity by cytokines in sickle erythrocytes. 2002 Blood pmid:11756192
Furukawa M et al. Presence of platelet-activating factor in nasal polyps and eosinophils. 2002 Acta Otolaryngol. pmid:12542208
Farmer PJ et al. Inhibition of prostaglandin G/H synthase unveils a potent effect of platelet activating factor on the permeability of bovine aortic endothelial cells to albumin. 2002 Inflammation pmid:12546134
Tselepis AD and John Chapman M Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. 2002 Atheroscler Suppl pmid:12573364
McKenna DJ et al. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. 2001 Sep-Oct Altern Ther Health Med pmid:11565403
de Souza LJ et al. Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis. 2001 Jul-Aug J. Gastrointest. Surg. pmid:11985976
Coker A et al. Is mannitol effective against platelet-activating factor (PAF)-induced liver damage in obstructive jaundice? 2001 Jul-Aug Hepatogastroenterology pmid:11490817
Dery RE et al. Inhibition of allergic inflammation by C-terminal peptides of the prohormone submandibular rat 1 (SMR-1). 2001 Jan-Mar Int. Arch. Allergy Immunol. pmid:11306968
Iwazaki S et al. FR128998 ameliorates liver injury in extended liver resection with ischemia in dogs. 2001 Jan-Feb Hepatogastroenterology pmid:11268964
Magai RM and Shukla SD Metabolic fate of [14C]-ethanol into endothelial cell phospholipids including platelet-activating factor, sphingomyelin and phosphatidylethanol. 2001 Jan-Feb J. Biomed. Sci. pmid:11173988
Denizot Y et al. Is there a role of platelet-activating factor in human lung cancer? 2001 Aug-Sep Lung Cancer pmid:11551414
Jolly S et al. Effect of intravenous platelet-activating factor on bovine pulmonary mast cells. 2001 Aug-Oct J. Comp. Pathol. pmid:11578122
Marathe GK et al. Oxidized LDL contains inflammatory PAF-like phospholipids. 2001 Apr-May Trends Cardiovasc. Med. pmid:11686003
Ulrich CD Lexipafant in severe acute pancreatitis: the final word? 2001 Curr Gastroenterol Rep pmid:11276374
Ishizuka S et al. Acid exposure stimulates the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells: effects on platelet-activating factor receptor expression. 2001 Am. J. Respir. Cell Mol. Biol. pmid:11306440
Hirashima Y et al. Effect of a platelet-activating factor receptor antagonist, E5880, on cerebral vasospasm after aneurysmal subarachnoid hemorrhage--open clinical trial to investigate efficacy and safety. 2001 Neurol. Med. Chir. (Tokyo) pmid:11381675
Liu XH et al. Platelet-activating factor antagonist BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats. 2001 Pediatr. Res. pmid:11385142
Mi B and Maleczka RE A Nozaki-Hiyama-Kishi Ni(II)/Cr(II) coupling approach to the phomactins. 2001 Org. Lett. pmid:11388849
Elzi DJ et al. Ionomycin causes activation of p38 and p42/44 mitogen-activated protein kinases in human neutrophils. 2001 Am. J. Physiol., Cell Physiol. pmid:11401859
Tiemann U et al. Platelet-activating factor (PAF)-like activity, localization of PAF receptor (PAF-R) and PAF-acetylhydrolase (PAF-AH) activity in bovine endometrium at different stages of the estrous cycle and early pregnancy. 2001 Prostaglandins Other Lipid Mediat. pmid:11403499
Tong N et al. Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. 2001 Eur. J. Neurosci. pmid:11403684
Roudebush WE Role of platelet-activating factor in reproduction: sperm function. 2001 Asian J. Androl. pmid:11404790
Tavakoli S et al. Prostaglandin E(2)-induced interleukin-6 release by a human airway epithelial cell line. 2001 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:11133502
Rodrigo L et al. Hydrolysis of platelet-activating factor by human serum paraoxonase. 2001 Biochem. J. pmid:11171072
Del Sorbo L et al. Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat. 2001 Eur. J. Immunol. pmid:11180101
Gandhi CR et al. A23187 causes release of inositol phosphates from cultured rat Kupffer cells. 2001 Eur. J. Pharmacol. pmid:11245846
Denis MA et al. Increased response of blood eosinophils to various chemotactic agents in quiescent Crohn disease. 2001 Scand. J. Gastroenterol. pmid:11252412
Storey RF et al. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood. 2001 Platelets pmid:11674863
Camici M and Sagripanti A Plasma platelet activating factor in nephrotic syndrome. 2001 Minerva Med. pmid:11675576
Kohno S and Nabe T [Inflammatory mediators (leukotrienes, thromboxane A2, tachykinins and others)]. 2001 Nippon Rinsho pmid:11676130
Pettorossi VE and Grassi S Different contributions of platelet-activating factor and nitric oxide in long-term potentiation of the rat medial vestibular nuclei. 2001 Acta Otolaryngol Suppl pmid:11677732
Wielockx B et al. Involvement of a serine protease, but not of neutrophil elastase, in tumor necrosis factor-induced lethal hepatitis and induction of platelet-activating factor. 2001 J. Hepatol. pmid:11682033
Bhatia M et al. Inflammatory mediators as therapeutic targets in acute pancreatitis. 2001 Curr Opin Investig Drugs pmid:11566005
Emingil G et al. Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases. 2001 J. Periodontol. pmid:11525434
Thomet OA et al. Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils. 2001 Clin. Exp. Allergy pmid:11529903
Watanabe S et al. Suppression of platelet-activating factor generation and modulation of arachidonate metabolism by dietary enrichment with (n-9) eicosatrienoic acid or docosahexaenoic acid in mouse peritoneal cells. 2001 Prostaglandins Other Lipid Mediat. pmid:11534547
Stafforini DM PAF acetylhydrolase gene polymorphisms and asthma severity. 2001 Pharmacogenomics pmid:11535107
Hourton D et al. Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity. 2001 Eur. J. Biochem. pmid:11502209
Velasquez LA et al. PAF receptor and PAF acetylhydrolase expression in the endosalpinx of the human Fallopian tube: possible role of embryo-derived PAF in the control of embryo transport to the uterus. 2001 Hum. Reprod. pmid:11473946
Akisu M et al. The role of recombinant human erythropoietin in lipid peroxidation and platelet-activating factor generation in a rat model of necrotizing enterocolitis. 2001 Eur J Pediatr Surg pmid:11475112
Murakami M et al. Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. 2001 J. Biol. Chem. pmid:11106649
Hiran T et al. Evidence for the involvement of the NADPH oxidase enzyme complex in the optimal accumulation of Platelet-activating factor in the human cell line PLB-985. 2001 Prostaglandins Other Lipid Mediat. pmid:11785782
Binisti C et al. Structure-activity relationships in platelet-activating factor (PAF). 11-From PAF-antagonism to phospholipase A(2) inhibition: syntheses and structure-activity relationships in 1-arylsulfamido-2-alkylpiperazines. 2001 Eur J Med Chem pmid:11738488
Tohda Y et al. Role of chemical mediators in airway hyperresponsiveness in an asthmatic model. 2001 Respiration pmid:11223734
Alam N et al. Additional bioactive Lyso-PAF congeners from the sponge Spirastrella abata. 2001 J. Nat. Prod. pmid:11325244